Ginkgo Bioworks
DNA
#7435
Rank
NZ$0.88 B
Marketcap
NZ$13.54
Share price
4.50%
Change (1 day)
-28.24%
Change (1 year)

Operating Margin for Ginkgo Bioworks (DNA)

Operating Margin as of July 2026 (TTM): -213.20%

According to Ginkgo Bioworks 's latest financial reports and stock price the company's current Operating Margin is -213.20%. At the end of 2025 the company had an Operating Margin of -184.30%.

Operating Margin history for Ginkgo Bioworks from 2021 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-184.30%-23.57%
2024-241.15%-32.09%
2023-355.11%-20.03%
2022-444.08%-24.18%
2021-585.69%259.66%
2020-162.85%-26.37%
2019-221.16%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.